Member Info for denby69

THE view I put over was just showing that peoples attitude and actions can change for a better world AFTER all is money not the rout of all Eval ?

This is nothing personal, but there is no consideration for other people these days. It is just a case , I AM ALL RIGHT AND greed as you have shown you do not care , Would it not be a better world, place, if people took the opposite view to you and cared we could Invest still but more people would prosper. ???

STOP SAYING ABOUT SELLING WANT THIS UP AS I AM UNDER WATER :-(

ARSENAL17 I totally agree with you try putting the right word for these people Punters NO Gamblers YES and the hedge funds

Formul1187 GOD I hope so want it to hit 20p resistance and more lol lets smash the resistance :-)
just to cheer me up lol

Its ok just ****ed off as this does not seam to be moving very fast in the right direction not de ramping ass I think this is a good product

could do with more news from Nigel about who N4P is talking to regarding Nuvec as share price is going Nowhere except down

MMMM their product Nuvec does not seem to Impress many pharmas ??? no approaches yet to use it ???
guess its a pump and dump share ???

260 by the end of the day

Hall123
what a load of crap any one can buy the shares this morning LOL I did

Excellent RNS this morning

May be our dear CEO should read below and focus some points for GSK and stop feathering her own nest with cheap shares. (and take a pay cut)

Management emphasised Merck's strategy of executing on its core business, expanding geographically in high-growth markets, extending its complementary businesses and focussing at managing costs while investing for growth.
The company stated that sales in emerging markets now accounted for about 20% of its pharmaceutical revenue, led by a 19% increase in China.
Merck benefits from a strong balance sheet and cash-generating ability. Along with a strong pipeline and product portfolio, this enables it to offset weakness in any single product.
The company said it plans to seek US regulatory approval by the end of 2013 for its insomnia drug suvorexant, its osteoporosis treatment odanacatib, and cholesterol drug tredaptive.
The group adopts a focus on shareholder return and operates a share buy-back programme.

there will be another chance to get arg as bit will drop again in the next 3 weeks

with the options taken up which will hit the market to-morrow should pick arg @248

I have all ways thought that they should have not got rid of interest rates, from a solvent Inverter

What a good Idea papucel

ya THEY get far to big a salaries now bring down the share and then feather their nests with shares that are over inflated

got 1 k more 12.24 happy no intension to sell will wait for the split now :-)

papucel,
So you have found out at last the stock markets are casinos and full of gamblers and the only way to make money is to invest in firms for the long term that you believe in ?

toff

most of these hedge funds have friends in the government so the FCA will do jack ****
the richer get richer and the poorer me get poorer lol